Restart Of The Johnson & Johnson COVID-19 Vaccine: A Doctor Explains Why Benefits Far Outweigh Risks

The FDA and CDC paused the use of the J&J vaccine on April 13, 2021 because of six initial cases of a rare and dangerous blood clot involving the cerebral venous sinuses, large blood vessels in the brain.